3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Meningioma
7
Brain Neoplasms
6
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
3
Glioblastoma
3
Stomach Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Esophageal Neoplasms
2
Central Nervous System Neoplasms
2
Thyroid Carcinoma, Anaplastic
1
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pharyngeal Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Nasopharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
6
Radiotherapy, Intensity-Modulated
5
Cisplatin
5
Carboplatin
5
Papillomavirus Vaccines
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
artesunic acid
3
artemisinin
3
Paclitaxel
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
artenimol
2
Vaccines, Synthetic
2
Taxes
2
Radiation
2
Imiquimod
2
GX-188 vaccine
2
Docetaxel
2
Albumin-Bound Paclitaxel
2
utomilumab
1
toripalimab
1
polyphenon E
1
infigratinib
1
fludarabine phosphate
1
fludarabine
1
epigallocatechin gallate
1
aldesleukin
1
Viusid
1
Vaccines
1
VP-102
1
Therapies, Investigational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Papillomavirus Infections
×
Hydroxyurea
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts